Glycodendritic structures as DC-SIGN binders to inhibit viral infections.
Javier Ramos-SorianoJavier RojoPublished in: Chemical communications (Cambridge, England) (2021)
DC-SIGN, a lectin discovered two decades ago, plays a relevant role in innate immunity. Since its discovery, it has turned out to be a target for developing antiviral drugs based on carbohydrates due to its participation in the infection process of several pathogens. A plethora of carbohydrate multivalent systems using different scaffolds have been described to achieve this goal. Our group has made significant contributions to this field, which are revised herein.